{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T05:05:45Z","timestamp":1771823145564,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.neurol.2019.08.009","type":"journal-article","created":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T10:10:20Z","timestamp":1571911820000},"page":"261-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Neuromyelitis optica spectrum disorders in South of Tunisia: A rare entity with low seroprevalence of anti-aquaporin 4 autoantibodies"],"prefix":"10.1016","volume":"176","author":[{"given":"S.","family":"Mejdoub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Feki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dammak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Farhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Hdiji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Boukthir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hachicha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mhiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Masmoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neurol.2019.08.009_bib0235","first-page":"41","article-title":"Histoire de la neuromy\u00e9lite optique de Devic","volume":"2","author":"De Seze","year":"2011","journal-title":"Prat Neurol - FMC"},{"issue":"1","key":"10.1016\/j.neurol.2019.08.009_bib0240","first-page":"21","article-title":"Prise en charge des neuropathies optiques inflammatoires","volume":"2","author":"De Seze","year":"2011","journal-title":"Prat Neurol - FMC"},{"issue":"2","key":"10.1016\/j.neurol.2019.08.009_bib0245","first-page":"112","article-title":"My\u00e9lopathies inflammatoires","volume":"5","author":"Marignier","year":"2014","journal-title":"Prat Neurol - FMC"},{"key":"10.1016\/j.neurol.2019.08.009_bib0250","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.neurol.2019.08.009_bib0255","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.neurol.2019.08.009_bib0260","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jaut.2014.05.004","article-title":"NMO spectrum of disorders: a paradigm for astrocyte-targeting autoimmunity and its implications for MS and other CNS inflammatory diseases","volume":"54","author":"Vaknin-Dembinsky","year":"2014","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.neurol.2019.08.009_bib0265","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2019.08.009_bib0270","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurol.2019.08.009_bib0275","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.frad.2015.05.003","article-title":"Formes atypiques de neuro-my\u00e9lite optique","volume":"55","author":"Bouzidi","year":"2015","journal-title":"Feuill Radiol"},{"key":"10.1016\/j.neurol.2019.08.009_bib0280","doi-asserted-by":"crossref","first-page":"A89","DOI":"10.1016\/j.neurol.2016.01.215","article-title":"Emergence de la NMO \u00e0 Ac anti-aquaporine positifs en Tunisie\u00a0: 3\u00a0observations et formes trompeuses","volume":"172","author":"Kchaou","year":"2016","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2019.08.009_bib0285","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.msard.2017.10.015","article-title":"Prevalence of neuromyelitis optica spectrum disorder in the multi-ethnic Penang Island, Malaysia, and a review of worldwide prevalence","volume":"19","author":"Hor","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurol.2019.08.009_bib0290","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1212\/WNL.0000000000004611","article-title":"Prevalence and clinical features of neuromyelitis optica spectrum disorders in northern Japan","volume":"89","author":"Houzen","year":"2017","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.neurol.2019.08.009_bib0295","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archneurol.2012.314","article-title":"Epidemiology of neuromyelitis optica in the United States","volume":"69","author":"Mealy","year":"2012","journal-title":"Arch Neurol"},{"issue":"18","key":"10.1016\/j.neurol.2019.08.009_bib0300","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.0b013e3182190f74","article-title":"A population-based study of neuromyelitis optica in Caucasians","volume":"76","author":"Asgari","year":"2011","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurol.2019.08.009_bib0305","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1468-1331.2011.03529.x","article-title":"The prevalence of neuromyelitis optica in South East Wales","volume":"19","author":"Cossburn","year":"2012","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2019.08.009_bib0310","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1474-4422(13)70233-3","article-title":"Body fluid biomarkers in multiple sclerosis","volume":"13","author":"Comabella","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2019.08.009_bib0315","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2018.05.015","article-title":"The intrathecal polyspecific antiviral immune response (MRZ reaction): a potential cerebrospinal fluid marker for multiple sclerosis diagnosis","volume":"321","author":"Feki","year":"2018","journal-title":"J Neuroimmunol"},{"issue":"12","key":"10.1016\/j.neurol.2019.08.009_bib0320","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.autrev.2015.07.014","article-title":"Peripheral blood biomarkers in multiple sclerosis","volume":"14","author":"D\u2019Ambrosio","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.neurol.2019.08.009_bib0325","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bpa.12084","article-title":"Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature","volume":"23","author":"Jarius","year":"2013","journal-title":"Brain Pathol"},{"key":"10.1016\/j.neurol.2019.08.009_bib0330","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cca.2014.11.004","article-title":"Biomarkers for neuromyelitis optica","volume":"440","author":"Chang","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"9","key":"10.1016\/j.neurol.2019.08.009_bib0335","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","article-title":"Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays","volume":"78","author":"Waters","year":"2012","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurol.2019.08.009_bib0340","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.clim.2010.11.012","article-title":"Strategy for anti-aquaporin-4 auto-antibody identification and quantification using a new cell-based assay","volume":"138","author":"De Vidi","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.neurol.2019.08.009_bib0345","first-page":"377","article-title":"Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders","volume":"133","author":"Hinson","year":"2016","journal-title":"Autoimmune Neurol"},{"issue":"13","key":"10.1016\/j.neurol.2019.08.009_bib0350","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/glia.20855","article-title":"Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies","volume":"57","author":"Nicchia","year":"2009","journal-title":"Glia"},{"issue":"5","key":"10.1016\/j.neurol.2019.08.009_bib0355","doi-asserted-by":"crossref","first-page":"e10455","DOI":"10.1371\/journal.pone.0010455","article-title":"Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica","volume":"5","author":"Mader","year":"2010","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.neurol.2019.08.009_bib0360","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurol.2019.08.009_bib0365","first-page":"34","article-title":"Neuromy\u00e9lite optique de Devic\u00a0: une forme particuli\u00e8re de SEP ou une entit\u00e9 isol\u00e9e\u00a0?","volume":"2","author":"De S\u00e8ze","year":"2010","journal-title":"Neurologie"},{"key":"10.1016\/j.neurol.2019.08.009_bib0370","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.msard.2015.11.008","article-title":"A previously misdiagnosed cohort of aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder with disease duration of>10 years in multi-ethnic Penang, Malaysia: clinical features and disease course","volume":"5","author":"Hor","year":"2016","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.neurol.2019.08.009_bib0375","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","article-title":"Neuromyelitis optica and non-organ-specific autoimmunity","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch Neurol"},{"issue":"9","key":"10.1016\/j.neurol.2019.08.009_bib0380","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.revmed.2009.08.018","article-title":"Syndrome de Goujerot-Sj\u00f6gren primitif et neuromy\u00e9lite optique de Devic","volume":"31","author":"Chourkani","year":"2010","journal-title":"Rev Med Interne"},{"issue":"1","key":"10.1016\/j.neurol.2019.08.009_bib0385","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-2094-10-8","article-title":"The history of neuromyelitis optica","volume":"10","author":"Jarius","year":"2013","journal-title":"J Neuroinflammation"},{"issue":"14","key":"10.1016\/j.neurol.2019.08.009_bib0390","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1212\/WNL.0b013e3182a6cb5c","article-title":"Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica","volume":"81","author":"Jiao","year":"2013","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2019.08.009_bib0395","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jns.2014.03.033","article-title":"Features of anti-aquaporin 4 antibody-seronegative Thai patients with neuromyelitis optica spectrum disorders: a comparison with seropositive cases","volume":"341","author":"Siritho","year":"2014","journal-title":"J Neurol Sci"},{"issue":"5","key":"10.1016\/j.neurol.2019.08.009_bib0400","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/brain\/awm027","article-title":"Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese","volume":"130","author":"Matsuoka","year":"2007","journal-title":"Brain"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2019.08.009_bib0405","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","article-title":"Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures","volume":"306","author":"Jarius","year":"2011","journal-title":"J Neurol Sci"},{"issue":"8","key":"10.1016\/j.neurol.2019.08.009_bib0410","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/jnnp-2012-302310","article-title":"Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders","volume":"84","author":"Jacob","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.neurol.2019.08.009_bib0415","first-page":"73","article-title":"Les atteintes de la substance blanche d\u2019origine dysimmunitaires","volume":"4","author":"De Seze","year":"2013","journal-title":"Prat Neurol - FMC"},{"key":"10.1016\/j.neurol.2019.08.009_bib0420","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neurol.2016.03.003","article-title":"Neuromyelitis optica spectrum disorder (NMOSD): a new concept","volume":"172","author":"De S\u00e8ze","year":"2016","journal-title":"Rev Neurol (Paris)"},{"issue":"5","key":"10.1016\/j.neurol.2019.08.009_bib0425","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s00415-008-0781-2","article-title":"Characteristics of Devic's disease (neuromyelitis optica) in Mexico","volume":"255","author":"Rivera","year":"2008","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2019.08.009_bib0430","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00415-009-0009-0","article-title":"An epidemiological study of neuromyelitis optica in Cuba","volume":"256","author":"Cabrera-G\u00f3mez","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2019.08.009_bib0435","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.msard.2017.10.007","article-title":"Neuromyelitis optica spectrum disorders in Iran","volume":"18","author":"Eskandarieh","year":"2017","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"10.1016\/j.neurol.2019.08.009_bib0440","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/cen3.12458","article-title":"Prevalence and characteristics of transverse myelitis and neuromyelitis optica spectrum disorders in the United Arab Emirates: a multicenter, retrospective study","volume":"9","author":"Holroyd","year":"2018","journal-title":"Clin Exp Neuroimmunol"},{"key":"10.1016\/j.neurol.2019.08.009_bib0445","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/jnnp-2016-314839","article-title":"Incidence and prevalence of NMOSD in Australia and New Zealand","volume":"88","author":"Bukhari","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2019.08.009_bib0450","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1212\/WNL.0b013e318296e917","article-title":"Aquaporin-4 antibody\u00a0\u2013\u00a0negative neuromyelitis optica: distinct assay sensitivity\u00a0\u2013\u00a0dependent entity","volume":"80","author":"Giraudon","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2019.08.009_bib0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/568254","article-title":"The frequency of anti-aquaporin-4 Ig G antibody in neuromyelitis optica and its spectrum disorders at a single tertiary referral center in Malaysia","volume":"2014","author":"Viswanathan","year":"2014","journal-title":"Mult Scler Int"},{"issue":"1","key":"10.1016\/j.neurol.2019.08.009_bib0460","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/1352458509353651","article-title":"Recurrent neuromyelitis optica in Brazilian patients: clinical, immunological, and neuroimaging characteristics","volume":"16","author":"Adoni","year":"2010","journal-title":"Mult Scler"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378719305934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378719305934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:40:37Z","timestamp":1758519637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378719305934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0035378719305934"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2019.08.009","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuromyelitis optica spectrum disorders in South of Tunisia: A rare entity with low seroprevalence of anti-aquaporin 4 autoantibodies","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2019.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}